INTRAVITREAL AFLIBERCEPT FOR MACULAR EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION
At the 5-year follow-up, intravitreal aflibercept showed a mean gain of 11.5 letters in BCVA with an average of 23.7 injections. 31.4% of patients achieved a treatment interval of ≥12 weeks, while about half of patients showed good treatment response.
Authors
- Ilias Georgalas (ORCID: https://orcid.org/0000-0002-6171-5865)
- Irini Chatziralli (ORCID: https://orcid.org/0000-0001-8523-1024)
- Efthymios Karmiris (ORCID: https://orcid.org/0000-0002-4091-9236)
- Paraskevi Theofilou (ORCID: https://orcid.org/0000-0002-3424-0243)
- George Theodossiadis (ORCID: https://orcid.org/0000-0002-5571-3206)
- PANAGIOTIS G. THEODOSSIADIS (ORCID: https://orcid.org/0000-0002-1460-0838)
- Dimitrios Kazantzis (ORCID: https://orcid.org/0000-0002-4145-8144)
- Chrysa Agapitou (ORCID: https://orcid.org/0009-0008-2778-9773)
- Alexia Risi‐Koziona
Institutions
- National and Kapodistrian University of Athens (GR)
- General Hospital of Athens G. Genimatas (GR)
Publication Details
- Journal
- Retina
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1097/iae.0000000000004477
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00